Core Viewpoint - The company has launched its oseltamivir phosphate granules for the treatment of influenza amid a widespread outbreak of H1N1, ensuring a stable supply of medications to meet seasonal demand [2]. Group 1: Product Availability - The company's subsidiary, Hunan Tianji Caotang Pharmaceutical Co., Ltd., has begun selling oseltamivir phosphate granules in major offline pharmacies across the country [2]. - The medication is suitable for patients aged 2 weeks and older for the treatment of both type A and type B influenza, and for prevention in patients aged 1 year and older [2]. Group 2: Market Response - The company has a range of over-the-counter medications available in its retail pharmacies, including fever reducers and cough suppressants, to address symptomatic treatment for influenza [2]. - In response to the seasonal increase in demand, the company has developed a production plan that allows for flexible adjustments in capacity based on market sales conditions, ensuring a safe and stable supply of medications [2].
达嘉维康：子公司生产的磷酸奥司他韦颗粒已陆续在全国各大线下药店同步上市销售